Vrolijk Misha F, Opperhuizen Antoon, Jansen Eugène H J M, Godschalk Roger W, Van Schooten Frederik J, Bast Aalt, Haenen Guido R M M
Department of Toxicology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
Department of Toxicology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands; Netherlands Food and Consumer Product Safety Authority (NVWA), 3540 AA Utrecht, The Netherlands.
Redox Biol. 2015;4:272-8. doi: 10.1016/j.redox.2014.12.017. Epub 2015 Jan 16.
Antioxidants are vital for aerobic life, and for decades the expectations of antioxidants as health promoting agents were very high. However, relatively recent meta-analyses of clinical studies show that supplementation of antioxidants does not result in the presumed health benefit, but is associated with increased mortality. The dilemma that still needs to be solved is: what are antioxidants in the end, healthy or toxic? We have evaluated this dilemma by examining the presumed health effects of two individual antioxidants with opposite images i.e. the "poisonous" β-carotene and the "wholesome" vitamin E and focused on one aspect, namely their role in inducing BPDE-DNA adducts. It appears that both antioxidants promote DNA adduct formation indirectly by inhibition of the protective enzyme glutathione-S-transferase π (GST π). Despite their opposite image, both antioxidants display a similar type of toxicity. It is concluded that, in the appreciation of antioxidants, first their benefits should be identified and substantiated by elucidating their molecular mechanism. Subsequently, the risks should be identified including the molecular mechanism. The optimal benefit-risk ratio has to be determined for each antioxidant and each individual separately, also considering the dose.
抗氧化剂对有氧生命至关重要,几十年来,人们对抗氧化剂作为促进健康的物质寄予厚望。然而,最近对临床研究的荟萃分析表明,补充抗氧化剂并不会带来预期的健康益处,反而与死亡率增加有关。仍有待解决的困境是:抗氧化剂到底是什么,有益健康还是有毒?我们通过研究两种形象相反的单一抗氧化剂,即“有毒的”β-胡萝卜素和“有益健康的”维生素E的假定健康影响来评估这一困境,并聚焦于一个方面,即它们在诱导BPDE-DNA加合物形成中的作用。似乎这两种抗氧化剂都通过抑制保护性酶谷胱甘肽-S-转移酶π(GST π)间接促进DNA加合物的形成。尽管它们形象相反,但这两种抗氧化剂都表现出类似的毒性类型。得出的结论是,在对抗氧化剂的评价中,首先应通过阐明其分子机制来确定并证实它们的益处。随后,应确定包括分子机制在内的风险。必须为每种抗氧化剂和每个个体分别确定最佳的效益风险比,同时也要考虑剂量。